top of page
  • Facebook
  • White Twitter Icon
  • Soundcloud
  • White Instagram Icon
  • LinkedIn
  • TikTok

Cannabis for Pain: Medical Cannabis Reduced Opioid Dosages for Chronic Pain

Updated: Apr 24, 2023

Welcome to homework assignment CPS 1.2 in the Cannabis for Pain seminar from Higher Learning LV. This seminar provides a review of recently published peer-reviewed scientific research on the topic of the potential medicinal efficacy of cannabis for pain. This assignment in particular focuses on a 2023 study about the potential results of cannabis legalization with respect to opioid usage and dosing.


When you complete this homework assignment, simply click the link at the bottom of the article to return to the master page for this seminar.

A 2023 study entitled "Changes in Prescribed Opioid Dosages Among Patients Receiving Medical Cannabis for Chronic Pain, New York State, 2017-2019" that was published in the Journal of the American Medical Association (JAMA) posed the query: "Is receiving medical cannabis for a longer duration associated with reducing prescription opioid dosages among patients receiving long-term opioid therapy?"

Want to read more?

Subscribe to curtarobbins.wixsite.com to keep reading this exclusive post.

Higher Learning LV

There are many ways to learn from us, including 👇🏽

Teaching the Commerce + Chemistry of Cannabis™

Did You Know?

The cannabis genome produces 100+ cannabinoids, 150+ terpenes, and 20 flavonoids.

These phytomolecules interact with the human endocannabinoid system (ECS) to produce wellness.

But it gets complex. Biphasic response curves, biosynthetic pathways, and acidic precursors all commingle. Subscribe to learn how. 

Copyright © 2023 Higher Learning LV. All Rights Reserved. Unauthorized reuse strictly prohibited.

bottom of page